<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font18">al. </span>
   <span class="font16">with </span>
   <span class="font14">for </span>
   <span class="font14">inhibitors </span>
   <span class="font13">inhibitor </span>
   <span class="font13">The </span>
   <span class="font13">are </span>
   <span class="font12">was </span>
   <span class="font12">furin </span>
   <span class="font12">protease </span>
   <span class="font12">proteases </span>
   <span class="font12">virus </span>
   <span class="font11">serine </span>
   <span class="font11">human </span>
   <span class="font11">which </span>
   <span class="font11">influenza </span>
   <span class="font11">also </span>
   <span class="font11">from </span>
   <span class="font11">that </span>
   <span class="font11">against </span>
   <span class="font11">its </span>
   <span class="font11">Fig. </span>
   <span class="font11">been </span>
   <span class="font11">inhibition </span>
   <span class="font11">potent </span>
   <span class="font11">cleavage </span>
   <span class="font11">matriptase </span>
   <span class="font11">their </span>
   <span class="font11">have </span>
   <span class="font11">found </span>
   <span class="font11">host </span>
   <span class="font11">trypsin-like </span>
   <span class="font11">TMPRSS </span>
   <span class="font11">Med </span>
   <span class="font11">treatment </span>
   <span class="font10">complex </span>
   <span class="font10">this </span>
   <span class="font10">inhibits </span>
   <span class="font10">trypsin </span>
   <span class="font10">{background </span>
   <span class="font10">analogue </span>
   <span class="font10">cysteine </span>
   <span class="font10">(Fig. </span>
   <span class="font10">binding </span>
   <span class="font10">site </span>
   <span class="font10">were </span>
   <span class="font10">activation </span>
   <span class="font10">cell </span>
   <span class="font10">most </span>
   <span class="font10">structure </span>
   <span class="font10">whereas </span>
   <span class="font10">not </span>
   <span class="font10">numerous </span>
   <span class="font10">these </span>
   <span class="font10">antiviral </span>
   <span class="font10">can </span>
   <span class="font10">cells </span>
   <span class="font10">containing </span>
   <span class="font10">like </span>
   <span class="font10">value </span>
   <span class="font10">but </span>
   <span class="font10">substrate </span>
   <span class="font10">(Ki </span>
   <span class="font10">However, </span>
   <span class="font10">cathepsin </span>
   <span class="font10">compound </span>
   <span class="font10">compounds </span>
   <span class="font10">has </span>
   <span class="font10">margin </span>
   <span class="font10">only </span>
   <span class="font10">other </span>
   <span class="font10">reduced </span>
   <span class="font10">Chem </span>
   <span class="font10">SKI-/SP </span>
   <span class="font10">residues </span>
   <span class="font10">used </span>
   <span class="font10">{border-style </span>
   <span class="font10">Biol </span>
   <span class="font10">PCs </span>
   <span class="font10">could </span>
   <span class="font10">drug </span>
   <span class="font10">factor </span>
   <span class="font10">pocket </span>
   <span class="font10">shown </span>
   <span class="font10">viral </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">basic </span>
   <span class="font10">crystal </span>
   <span class="font10">proprotein </span>
   <span class="font10">px;} </span>
   <span class="font10">side </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">active </span>
   <span class="font10">processing </span>
   <span class="font10">protein </span>
   <span class="font10">viruses </span>
   <span class="font10">PC, </span>
   <span class="font10">after </span>
   <span class="font10">described </span>
   <span class="font10">development </span>
   <span class="font10">mice </span>
   <span class="font10">potency </span>
   <span class="font10">structures </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">inhibit </span>
   <span class="font10">involved </span>
   <span class="font10">peptide </span>
   <span class="font10">selective </span>
   <span class="font10">should </span>
   <span class="font10">surface </span>
   <span class="font10">thrombin </span>
   <span class="font10">well </span>
   <span class="font10">This </span>
   <span class="font10">Virol./JVI.- </span>
   <span class="font10">active-site </span>
   <span class="font10">analogues </span>
   <span class="font10">covalent </span>
   <span class="font10">more </span>
   <span class="font10">proteases. </span>
   <span class="font10">relatively </span>
   <span class="font10">substrates </span>
   <span class="font10">suitable </span>
   <span class="font10">two </span>
   <span class="font10">type </span>
   <span class="font10">For </span>
   <span class="font10">additional </span>
   <span class="font10">further </span>
   <span class="font10">values </span>
   <span class="font10">derivatives </span>
   <span class="font10">design </span>
   <span class="font10">due </span>
   <span class="font10">few </span>
   <span class="font10">group </span>
   <span class="font10">nM) </span>
   <span class="font10">potential </span>
   <span class="font10">residue </span>
   <span class="font10">some </span>
   <span class="font10">target </span>
   <span class="font10">targeting </span>
   <span class="font10">targets </span>
   <span class="font10">(Basak </span>
   <span class="font10">IAV </span>
   <span class="font10">amino </span>
   <span class="font10">binds </span>
   <span class="font10">catalytic </span>
   <span class="font10">constant </span>
   <span class="font10">coronavirus </span>
   <span class="font10">domain </span>
   <span class="font10">during </span>
   <span class="font10">first </span>
   <span class="font10">fusion </span>
   <span class="font10">receptor </span>
   <span class="font10">several </span>
   <span class="font10">similar </span>
   <span class="font10">specific </span>
   <span class="font10">studies </span>
   <span class="font10">they </span>
   <span class="font10">Although </span>
   <span class="font10">Moreover, </span>
   <span class="font10">PACE </span>
   <span class="font10">airway </span>
   <span class="font10">aprotinin </span>
   <span class="font10">arginine </span>
   <span class="font10">derivative </span>
   <span class="font10">drugs </span>
   <span class="font10">enzyme </span>
   <span class="font10">furin, </span>
   <span class="font10">high </span>
   <span class="font10">including </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">into </span>
   <span class="font10">known </span>
   <span class="font10">less </span>
   <span class="font10">membrane </span>
   <span class="font10">might </span>
   <span class="font10">model </span>
   <span class="font10">new </span>
   <span class="font10">novel </span>
   <span class="font10">replication </span>
   <span class="font10">small-molecule </span>
   <span class="font10">therapeutic </span>
   <span class="font10">transmembrane </span>
   <span class="font10">vitro </span>
   <span class="font10">within </span>
   <span class="font10">(PDB, </span>
   <span class="font10">-mer </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">N-terminal </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">TTSPs </span>
   <span class="font10">These </span>
   <span class="font10">activated </span>
   <span class="font10">activity </span>
   <span class="font10">affinity </span>
   <span class="font10">all </span>
   <span class="font10">approved </span>
   <span class="font10">both </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cancer </span>
   <span class="font10">carbon </span>
   <span class="font10">different </span>
   <span class="font10">e.g., </span>
   <span class="font10">enzymes </span>
   <span class="font10">family </span>
   <span class="font10">growth </span>
   <span class="font10">hemagglutinin </span>
   <span class="font10">infection </span>
   <span class="font10">irreversible </span>
   <span class="font10">leads </span>
   <span class="font10">monobasic </span>
   <span class="font10">nM, </span>
   <span class="font10">peptidic </span>
   <span class="font10">position </span>
   <span class="font10">possess </span>
   <span class="font10">proteases, </span>
   <span class="font10">respiratory </span>
   <span class="font10">strongly </span>
   <span class="font10">such </span>
   <span class="font10">than </span>
   <span class="font10">when </span>
   <span class="font10">.). </span>
   <span class="font10">Acad </span>
   <span class="font10">Biophys </span>
   <span class="font10">Chem./jbc.M </span>
   <span class="font10">Despite </span>
   <span class="font10">Drug </span>
   <span class="font10">Furin </span>
   <span class="font10">HAs </span>
   <span class="font10">Host </span>
   <span class="font10">Rev </span>
   <span class="font10">SFTI- </span>
   <span class="font10">Structures </span>
   <span class="font10">TMPRSS, </span>
   <span class="font10">above </span>
   <span class="font10">achieved </span>
   <span class="font10">atoms </span>
   <span class="font10">backbone </span>
   <span class="font10">clinical </span>
   <span class="font10">combination </span>
   <span class="font10">distal </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">efficacy </span>
   <span class="font10">far, </span>
   <span class="font10">furin-like </span>
   <span class="font10">highly </span>
   <span class="font10">inhibitory </span>
   <span class="font10">low </span>
   <span class="font10">nonpeptidic </span>
   <span class="font10">observed </span>
   <span class="font10">plasma </span>
   <span class="font10">provided </span>
   <span class="font10">px; </span>
   <span class="font10">reversible </span>
   <span class="font10">second </span>
   <span class="font10">sequence </span>
   <span class="font10">sequences </span>
   <span class="font10">small </span>
   <span class="font10">spike </span>
   <span class="font10">strategy </span>
   <span class="font10">synthetic </span>
   <span class="font10">trypsin, </span>
   <span class="font10">use </span>
   <span class="font10">{font-family </span>
   <span class="font10">Ebola </span>
   <span class="font10">Lett./j.bmcl... </span>
   <span class="font10">Trp </span>
   <span class="font10">Virus </span>
   <span class="font10">acid </span>
   <span class="font10">acute </span>
   <span class="font10">addressing </span>
   <span class="font10">available </span>
   <span class="font10">based </span>
   <span class="font10">cathepsins </span>
   <span class="font10">clotting </span>
   <span class="font10">contrast, </span>
   <span class="font10">convertase </span>
   <span class="font10">derived </span>
   <span class="font10">developed </span>
   <span class="font10">enhanced </span>
   <span class="font10">font-size </span>
   <span class="font10">form </span>
   <span class="font10">groups </span>
   <span class="font10">important </span>
   <span class="font10">infected </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">instance, </span>
   <span class="font10">many </span>
   <span class="font10">mode </span>
   <span class="font10">molecule </span>
   <span class="font10">one </span>
   <span class="font10">peptides </span>
   <span class="font10">polar </span>
   <span class="font10">proteolytic </span>
   <span class="font10">selectivity </span>
   <span class="font10">severe </span>
   <span class="font10">significant </span>
   <span class="font10">spread </span>
   <span class="font10">stable </span>
   <span class="font10">tested </span>
   <span class="font10">them </span>
   <span class="font10">using </span>
   <span class="font10">various </span>
   <span class="font10">via </span>
   <span class="font10">where </span>
   <span class="font10">will </span>
   <span class="font10">(), </span>
   <span class="font10">(Dahms </span>
   <span class="font10">-Amba </span>
   <span class="font10">Based </span>
   <span class="font10">C-terminal </span>
   <span class="font10">Due </span>
   <span class="font10">HAT, </span>
   <span class="font10">Influenza </span>
   <span class="font10">Natl </span>
   <span class="font10">Numerous </span>
   <span class="font10">Res </span>
   <span class="font10">Sci </span>
   <span class="font10">Serine </span>
   <span class="font10">Therefore, </span>
   <span class="font10">activate </span>
   <span class="font10">activating </span>
   <span class="font10">activator </span>
   <span class="font10">although </span>
   <span class="font10">belongs </span>
   <span class="font10">blocks </span>
   <span class="font10">cellular </span>
   <span class="font10">chain </span>
   <span class="font10">cleaved </span>
   <span class="font10">close </span>
   <span class="font10">contrast </span>
   <span class="font10">convertases </span>
   <span class="font10">double; </span>
   <span class="font10">epithelial </span>
   <span class="font10">examples </span>
   <span class="font10">improved </span>
   <span class="font10">inhibitorsJ </span>
   <span class="font10">interactions </span>
   <span class="font10">knockout </span>
   <span class="font10">mainly </span>
   <span class="font10">nitrile </span>
   <span class="font10">oral </span>
   <span class="font10">oxygen </span>
   <span class="font10">plasmin, </span>
   <span class="font10">prepared </span>
   <span class="font10">propagation </span>
   <span class="font10">proteins </span>
   <span class="font10">reached </span>
   <span class="font10">red </span>
   <span class="font10">risk </span>
   <span class="font10">series </span>
   <span class="font10">sites </span>
   <span class="font10">strains </span>
   <span class="font10">strong </span>
   <span class="font10">structure-based </span>
   <span class="font10">tumor </span>
   <span class="font10">very </span>
   <span class="font10">vivo </span>
   <span class="font10">(Becker </span>
   <span class="font10">(Cameron </span>
   <span class="font10">(Hardes </span>
   <span class="font10">(Seidah </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Asp </span>
   <span class="font10">Cell </span>
   <span class="font10">Crystal </span>
   <span class="font10">HAT </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Mol </span>
   <span class="font10">Nipah </span>
   <span class="font10">PACE, </span>
   <span class="font10">PCSK </span>
   <span class="font10">PF- </span>
   <span class="font10">Proteases </span>
   <span class="font10">Structure </span>
   <span class="font10">With </span>
   <span class="font10">address </span>
   <span class="font10">and/or </span>
   <span class="font10">anthrax </span>
   <span class="font10">approximately </span>
   <span class="font10">because </span>
   <span class="font10">between </span>
   <span class="font10">bind </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bottom </span>
   <span class="font10">camostat </span>
   <span class="font10">characteristic </span>
   <span class="font10">characterization </span>
   <span class="font10">chloromethyl </span>
   <span class="font10">constants </span>
   <span class="font10">contacts </span>
   <span class="font10">cultures </span>
   <span class="font10">direct </span>
   <span class="font10">effects. </span>
   <span class="font10">efficiently </span>
   <span class="font10">endosomal </span>
   <span class="font10">enzymes, </span>
   <span class="font10">excellent </span>
   <span class="font10">extracellular </span>
   <span class="font10">far. </span>
   <span class="font10">glycine </span>
   <span class="font10">intracellular </span>
   <span class="font10">isolated </span>
   <span class="font10">leading </span>
   <span class="font10">lower </span>
   <span class="font10">lysine </span>
   <span class="font10">matriptase, </span>
   <span class="font10">moderate </span>
   <span class="font10">molecular </span>
   <span class="font10">molecules </span>
   <span class="font10">multibasic </span>
   <span class="font10">nanomolar </span>
   <span class="font10">natural </span>
   <span class="font10">obtained </span>
   <span class="font10">often </span>
   <span class="font10">optimization </span>
   <span class="font10">orally </span>
   <span class="font10">pathogenic </span>
   <span class="font10">phase </span>
   <span class="font10">presence </span>
   <span class="font10">prodomain </span>
   <span class="font10">prodrug </span>
   <span class="font10">rat </span>
   <span class="font10">receptor-binding </span>
   <span class="font10">recognition </span>
   <span class="font10">related </span>
   <span class="font10">required </span>
   <span class="font10">residue, </span>
   <span class="font10">respectively. </span>
   <span class="font10">revealed </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">same </span>
   <span class="font10">scaffold </span>
   <span class="font10">show </span>
   <span class="font10">shows </span>
   <span class="font10">solid; </span>
   <span class="font10">soluble </span>
   <span class="font10">still </span>
   <span class="font10">stronger </span>
   <span class="font10">study </span>
   <span class="font10">suggested </span>
   <span class="font10">sunflower </span>
   <span class="font10">thrombin, </span>
   <span class="font10">toxin </span>
   <span class="font10">viruses, </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Böttcher-Friebertshäuser </span>
   <span class="font10">(Goswami </span>
   <span class="font10">(Hammami </span>
   <span class="font10">(Maiwald </span>
   <span class="font10">(Siklos </span>
   <span class="font10">(Steinmetzer </span>
   <span class="font10">(Zhirnov </span>
   <span class="font10">-amidinobenzylamide </span>
   <span class="font10">A./pnas. </span>
   <span class="font10">ACE </span>
   <span class="font10">AEBSF </span>
   <span class="font10">After </span>
   <span class="font10">Besides </span>
   <span class="font10">CMK </span>
   <span class="font10">CoV </span>
   <span class="font10">Compound </span>
   <span class="font10">Consequently, </span>
   <span class="font10">DPP </span>
   <span class="font10">Discov./nrd </span>
   <span class="font10">ECA </span>
   <span class="font10">HIV- </span>
   <span class="font10">Hardes </span>
   <span class="font10">Its </span>
   <span class="font10">LASV </span>
   <span class="font10">Lys </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Matriptase </span>
   <span class="font10">Most </span>
   <span class="font10">One </span>
   <span class="font10">Opin </span>
   <span class="font10">P-P </span>
   <span class="font10">PCs. </span>
   <span class="font10">Prat </span>
   <span class="font10">Proprotein </span>
   <span class="font10">Protease </span>
   <span class="font10">Res./j.antiviral... </span>
   <span class="font10">Table </span>
   <span class="font10">activates </span>
   <span class="font10">activity. </span>
   <span class="font10">addition, </span>
   <span class="font10">adjacent </span>
   <span class="font10">aerosol </span>
   <span class="font10">amides </span>
   <span class="font10">any </span>
   <span class="font10">approach </span>
   <span class="font10">avian </span>
   <span class="font10">b). </span>
   <span class="font10">better </span>
   <span class="font10">bicyclic </span>
   <span class="font10">bioavailability </span>
   <span class="font10">block </span>
   <span class="font10">blocked </span>
   <span class="font10">blue, </span>
   <span class="font10">bold </span>
   <span class="font10">breast </span>
   <span class="font10">cannot </span>
   <span class="font10">case </span>
   <span class="font10">cells. </span>
   <span class="font10">certain </span>
   <span class="font10">cleavages </span>
   <span class="font10">compared </span>
   <span class="font10">complexed </span>
   <span class="font10">complexes </span>
   <span class="font10">concentrations </span>
   <span class="font10">contact </span>
   <span class="font10">contain </span>
   <span class="font10">courier; </span>
   <span class="font10">culture </span>
   <span class="font10">cycle </span>
   <span class="font10">decarboxylated </span>
   <span class="font10">determined </span>
   <span class="font10">development. </span>
   <span class="font10">discovery </span>
   <span class="font10">domains </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">experimental </span>
   <span class="font10">expression </span>
   <span class="font10">failed </span>
   <span class="font10">field </span>
   <span class="font10">following </span>
   <span class="font10">function </span>
   <span class="font10">glycoproteins </span>
   <span class="font10">hepatocyte </span>
   <span class="font10">hepsin, </span>
   <span class="font10">identified </span>
   <span class="font10">inactive </span>
   <span class="font10">incorporation </span>
   <span class="font10">infections. </span>
   <span class="font10">infectious </span>
   <span class="font10">inhibited </span>
   <span class="font10">initial </span>
   <span class="font10">interaction </span>
   <span class="font10">kallikrein </span>
   <span class="font10">ketones </span>
   <span class="font10">lead </span>
   <span class="font10">localization </span>
   <span class="font10">makes </span>
   <span class="font10">may </span>
   <span class="font10">measles </span>
   <span class="font10">modification </span>
   <span class="font10">motif </span>
   <span class="font10">mutation </span>
   <span class="font10">nM. </span>
   <span class="font10">nanobodies </span>
   <span class="font10">nitrogen </span>
   <span class="font10">patients </span>
   <span class="font10">peptidase </span>
   <span class="font10">physiological </span>
   <span class="font10">plasmin </span>
   <span class="font10">poor </span>
   <span class="font10">possesses </span>
   <span class="font10">possible </span>
   <span class="font10">precursor </span>
   <span class="font10">preferably </span>
   <span class="font10">preference </span>
   <span class="font10">promising </span>
   <span class="font10">proteinase </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">range </span>
   <span class="font10">rapid </span>
   <span class="font10">reactive </span>
   <span class="font10">recently </span>
   <span class="font10">recombinant </span>
   <span class="font10">regulation </span>
   <span class="font10">replacement </span>
   <span class="font10">reported </span>
   <span class="font10">respectively </span>
   <span class="font10">seasonal </span>
   <span class="font10">segment </span>
   <span class="font10">short </span>
   <span class="font10">showed </span>
   <span class="font10">significantly </span>
   <span class="font10">single </span>
   <span class="font10">site, </span>
   <span class="font10">sticks </span>
   <span class="font10">structural </span>
   <span class="font10">suited </span>
   <span class="font10">sulfonylated </span>
   <span class="font10">syndrome </span>
   <span class="font10">synthesis </span>
   <span class="font10">synthesized </span>
   <span class="font10">targets. </span>
   <span class="font10">therefore </span>
   <span class="font10">triad </span>
   <span class="font10">tribasic </span>
   <span class="font10">typical </span>
   <span class="font10">variant </span>
   <span class="font10">virus, </span>
   <span class="font10">viruses. </span>
   <span class="font10">water </span>
   <span class="font10">weak </span>
   <span class="font10">widely </span>
   <span class="font10">μM) </span>
   <span class="font10">μM. </span>
  </p>
 </body>
</html>
